Catalis SE
- WKN: 927093
- ISIN: NL0000233625
- Land: Niederlande
Nachricht vom 20.08.2012 | 17:17
Catalis SE: Catalis SE capital increase has been successfully completed
Catalis SE / Key word(s): Corporate Action
20.08.2012 17:17
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Ad hoc Release: Catalis SE capital increase has been successfully completed
Eindhoven, August 20, 2012 - Catalis SE, the worldwide service provider for
the digital media industry announces that it has successfully completed its
recent capital increase. The new 2.000.000 shares from a capital increase
against cash from authorized capital were offered to institutional
investors in a private placement. The shares were allocated at a price of
EUR 0.10 per share.
Through this capital increase, the company's share capital rises from EUR
6,042,332.80 to EUR 6,242,332.80 divided into 62,423,328 shares at a
nominal value of EUR 0.10 per share. The proceeds from this transaction
amount to approx. EUR 0.2 million. These proceeds are intended to
strengthen the company's capital base.
The shares were issued via private placement to particular investors
without pre-emptive rights. No pre-emptive rights trading took place.
The placement period started on Wednesday, August 15, 2012 and ended on
Friday, August 17, 2012. The capital increase and the process for admitting
and including the shares in official stock market trading, for which no
prospectus has been issued, is accompanied by ACON Actienbank AG.
For further information on Catalis SE and its wholly owned subsidiaries,
Testronic Labs, DDP and Kuju, please refer to www.catalisgroup.com,
www.testroniclabs.com, www.doublesixgames.com and www.kuju.com.
For further questions please contact our Investor Relations team directly:
Catalis SE
Investor Relations Team
t: +49 89 24 41 18 - 413
f: +49 89 24 41 18 - 499
info@catalisgroup.com
About Catalis SE:
Catalis is a worldwide leading outsourcing provider focusing on high-end
technical services relating to the creation of digital content for the
film, video games and software industries. Catalis offers both testing and
development services. It operates through its wholly-owned subsidiaries
Testronic Labs, Kuju and DDP from ten locations throughout the US, the UK,
Poland, Belgium, the Netherlands and the Czech Republic.
20.08.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Catalis SE
Geldropseweg 26-28
5611 SJ Eindhoven
Netherlands
Phone: +31 (0)40 2135930
Fax: +31 (0)40 2135604
E-mail: info@catalisgroup.com
Internet: www.catalisgroup.com
ISIN: NL0000233625
WKN: 927093
Listed: Regulierter Markt in Frankfurt (General Standard);
Freiverkehr in Berlin, Düsseldorf, München, Stuttgart
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Interaktiv
Anleihe im Fokus
Die DF-Anleihe 7,875%
Mit der DF Forfait AG vom wachsenden Welthandel profitieren
- Zeichnungsfrist: 21.05. bis 24.05.2013
- Laufzeit: 7 Jahre
- Kupon: 7,875% p.a.
- Volumen: bis zu 30 Mio. Euro
- ISIN: DE000A1R1CC4
Anleihe im Fokus
7,75% p.a. - Rendite aus Familienhand
– Zeichnungsstart: 23. Mai – Börse Frankfurt
– Zeichnung ab 1.000 Euro
– Laufzeit 5 Jahre
– WKN: A1TNA7
– 100% Rückzahlungskurs
GBC-Fokusbox
HELMA Eigenheimbau AG: Kaufen
Die HELMA Eigenheimbau AG präsentierte für das Geschäftsjahr 2012 Rekordwerte. Auf Basis unseres DCF-Modells haben wir einen fairen Wert je Aktie von 22,75 € ermittelt. Ausgehend vom erwarteten 2013er-EPS von 1,64 € entspricht dies einem KGV von 8,4. Das Kurspotenzial beläuft sich auf nahezu 65%.
Der AKTIONÄR News

19. Mai 14:30 Investieren wie Warren Buffett: Verdienen Sie 4.809 Euro in den ...
19. Mai 10:30 Lufthansa und die Angst vor dem Streik
19. Mai 09:00 ThyssenKrupp: Es bleibt spannend
19. Mai 08:00 Die Prognosen der Profis
19. Mai 07:30 Talanx: Analysten heben den Daumen
News im Fokus
Fresenius Medical Care AG & Co. KGaA: Bekanntmachung nach Art. 4 Abs. 2 der Verordnung (EG) Nr. 2273/2003
17. Mai 2013, 17:35
Aktuelle Research-Studie
Original-Research: Plan Optik AG (von GBC AG): Kaufen Plan Optik AG
17. Mai 2013
